Biorem (FRA:R6D) Common Stock: €3.28 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:R6D Biorem Inc FRA:R6D
67 GF Score
Price €1.84
GF Value €1.67
Valuation Fairly Valued
View Full Analysis

What is Biorem Common Stock?

Biorem FRA:R6D -0.54% 67 Common Stock is €3.28 Mil as of Mar. 2026. GuruFocus rates FRA:R6D with a GF Score™ of 67/100 and a GF Value™ of €1.67 (Fairly Valued).

Biorem's quarterly common stock increased from Sep. 2025 (€3.19 Mil) to Dec. 2025 (€3.22 Mil) and increased from Dec. 2025 (€3.22 Mil) to Mar. 2026 (€3.28 Mil).

Biorem's annual common stock increased from Dec. 2023 (€3.42 Mil) to Dec. 2024 (€3.48 Mil) but then declined from Dec. 2024 (€3.48 Mil) to Dec. 2025 (€3.22 Mil).

Biorem Common Stock Historical Data

* Premium members only.

The historical data trend for Biorem's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biorem Common Stock Chart

Biorem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.39 3.41 3.42 3.48 3.22

Biorem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.35 3.30 3.19 3.22 3.28
FRA:R6D
67GF Score
Biorem Inc FRA:R6D
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biorem Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €3.28 Mil mean?
Biorem (FRA:R6D) has a Common Stock of €3.28 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biorem and its competitors.
Is Biorem's Common Stock too high?
Biorem's current Common Stock is €3.28 Mil. Overall, Biorem has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Common Stock compare to VLTO and ZWS?
Biorem's Common Stock of €3.28 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for an Industrial Products company?
A good Common Stock depends on the Industrial Products industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Biorem and its competitors. Biorem's current Common Stock is €3.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (FRA:R6D) is currently considered Fairly Valued. The stock's GF Value™ is €1.67, compared to a current price of €1.84 — trading 10.2% above its estimated fair value. The current Common Stock is €3.28 Mil. Biorem's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Biorem (FRA:R6D), the current Common Stock is €3.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biorem (FRA:R6D) Overvalued in 2026?

Based on GuruFocus' analysis, Biorem stock appears to be overvalued. The current stock price of €1.84 is trading 10.2% above its estimated GF Value™ of €1.67. GuruFocus considers Biorem to be Fairly Valued.

Key valuation signals for FRA:R6D:

  • Common Stock: €3.28 Mil
  • GF Value™: €1.67 vs. price of €1.84 (10.2% above fair value)
  • GF Score™: 67/100

No single metric tells the full story. See the FRA:R6D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biorem Business Description

Other Exchanges BIRMF:USABRM:Canada
Address 7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
67GF Score

Get the complete analysis for FRA:R6D

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.84
Price
€1.67
GF Value